Xeris Pharmaceuticals Garners $1,500,000 Series A Round

  • Feed Type
  • Date
  • Company Name
    Xeris Pharmaceuticals
  • Mailing Address
    3925 West Braker Lane Third Floor Austin, TX 78759
  • Company Description
    Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology. The company’s disruptive formulation and delivery technologies allow for the subcutaneous delivery of highly concentrated, non-aqueous paste and liquid formulations of all drug classes, including small molecules, peptides, proteins, antibodies, and nucleic-acid-based therapeutics.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Central Texas Angel Network
  • Venture Investor

Trending on Xconomy